NCT07062614View on ClinicalTrials.gov

Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a Diagnostic Tool for Partial and/or Total Non-compliance With Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 3, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

June 30, 2027

Conditions
HIV (Human Immunodeficiency Virus)
Interventions
OTHER

Hair sampling and questionnaires answers for Patients with Lamivudine or Emtricitabine treatment

at inclusion, 3 months and 6 months of follow-up, patients must answer the Girerd compliance questionnaire. After 6 months of follow-up, two strands of hair will be taken from the base of the skull using scissors

Trial Locations (1)

31059

Infectious and Tropical Diseases Department, Purpan University Hospital, Toulouse Place du Docteur Baylac, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER